Identifying Uses for Immunotherapy Across Sarcoma Populations and SubtypesBySteven Bialick, DOApril 11th 2026Microsatellite instability-high status may make patients suitable candidates to receive agents like pembrolizumab, according to Steven Bialick, DO.